<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Vinall, Phil</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Bilous, Rudolf</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Diabetes and CKD Guidelines Update</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2012</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2012-08-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">27-28</style></pages><abstract><style  face="normal" font="default" size="100%">This article discusses the 2012 revisions to the National Kidney Foundation and Kidney Disease Outcomes Quality Initiative 2007 guidelines. Revisions were made in Guideline 2 (Management of Hyperglycemia and General Diabetes Care in Chronic Kidney Disease [CKD]), Guideline 4 (Management of Dyslipidemia in Diabetes and Chronic Kidney Disease), and Guideline 6 (Management of Albuminuria in Normotensive Patients With Diabetes).</style></abstract><number><style face="normal" font="default" size="100%">10</style></number><volume><style face="normal" font="default" size="100%">12</style></volume></record></records></xml>